Technical Revision Only to the Medicare Benefit Policy (MBP) Manual, Publication (Pub) 100-02, Chapter 15, section 50.4.2

The purpose of Change Request (CR) 13829 is to announce a technical change made to the Medicare Benefit Policy Manual, (Pub) 100-02, Chapter 15, section 50.4.2. CMS has identified a typo in the MBP Manual, Chapter 15, section 50.4.2 (Unlabeled Use of Drug). There is nothing included in this update that revises current coverage policy and that has not already been conveyed to the public via previous CRs. The proposed manual change includes a typo within section 50.4.2. The manual text reference is being revised from 50.5 (Self-Administered Drugs and Biologicals) to 50.4.5 (Off-Label Use of Drugs and Biologicals in an Anti-Cancer Chemotherapeutic Regimen).